2018
J&J Vision (formerly AMO)/ Tango Study
Clinical Investigation of the TECNIS Next-Generation Intraocular Lenses
Protocol # SUR-CAT-1001
2016
J&J Vision (formerly AMO)/ Thor Study
Clinical Investigation of the Bacterially-Derived Healon5 Ophthalmic Viscosurgical Device (OVD)
Protocol # VSCO-109-HLN5
ALCON (formerly TRANSCEND) / Compass XT Trial
An observational multicenter clinical study to assess the long-term safety of the Cypass Micro-Stent Glaucoma implant in patients with primary open angle glaucoma who have completed participation in the Compass Trial (#TMI-09-01)
Protocol # TMI-09-01-E
2015
AMO / Grand Tetons Study (IOL-Post Market Study)
Post approval Study of the Technis Toric IOL Extended Cylinder Range, ZCT450, ZCT525, and ZCT600
Protocol # TIOL-204-EPAS
AERIE / Mercury 1 Trial
A prospective, double-masked, randomized, multi-center, active-controlled, parallel-group 12-month study assessing the safety and ocular hypotensive efficacy of PG324
Ophthalmic Solution compared to AR-13324 Ophthalmic Solution,0.02% and Latanoprost
Ophthalmic Solution, 0.005% in subjects with elevated intraocular pressure.
AMO / Denali Study (IOL-Post Market Study)
Post approval Study of the Technis Toric IOL, Models ZCT300 and ZCT400
Protocol # TIOL-202-TPAS
AMO / Maestro Study
Clinical Investigation of the Technis Symfony Extended Range of Vision IOL, Model ZXR00
B&L / 843 Study
Efficacy and Safety of Loteprednol Etabonate Gel 0.38% vs. Vehicle Gel for treatment of Ocular inflammation and pain following cataract surgery (B&L 843)
2014
AMO / Whitney Study
Qualitative Validation of PRO instruments for the Post Approval study of the Technis Toric Lens, models ZCT300 and ZCT400
Protocol # TIOL-201-VPAS
AMO / PRO Study
Qualitative Validation of PRO instruments for the assessment of Spectacle Independence and Visual symptoms
Protocol # QPRO-101-SIVQ
2013
AMO / Low Add IOL
IOL
Protocol # DIOL-106-ZMLA
GLAUKOS / (iStent – Post Market Study)
iStent Glaucoma implant
Protocol # GTS100-PAS2
TRANSCEND / Compass Trial:
Cypass Glaucoma implant
Protocol # TMI-09-01
2012
VISIOGEN (AMO) / Synchrony Dual Optic IOL
IOL
Protocol # SYNC-601-IOL
2011
ISTA / Xibrom 0.4% – 0.8%
Efficacy and Safety of bromfenac Ophth sol vs. Placebo for treatment of Ocular inflammation and pain associated with cataract surgery (#S00124 )
ALCON / Brinz/Brim
Efficacy & Safety of Fixed combo Brinzolamide 1% & Brimonidine 0.2% compared to
Brinzolamide 1% and Brimonidine 0.2% (#C-10-033)
AMO / Toric IOL
IOL
Protocol # TIOL-103-TCNS
HOYA / The iSert 251
Preloaded single piece IOL (#2010-N251)
2010
AMO / VITRAX II
Viscoelastic
Protocol # VSCO-106-DISP
2009
ISTA / Xibrom 0.09%
Efficacy and Safety of bromfenac Ophth sol vs. Placebo for treatment of Ocular inflammation and pain associated with cataract surgery (CL-S&E-1205081-P)
2007
STAAR SURGICAL / ICL HYPEROPIC STUDY
Implantable Contact Lens to treat moderate – high myopia
2004
AMO / VITRAX
Viscoelastic
Protocol # VSCO-105-LRCT